Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area jak stat signaling stat'

Search results for: 'research area jak stat signaling stat'

Items 11-20 of 20

Page
per page
  1. SB525334
    A5602 SB525334
    Summary: (TGF-beta1) receptor inhibitor
      ≥34.3 mg/mL
  2. SB1317
    A3794 SB1317
    Summary: CDK,JAK and FLT inhibitor
      insoluble in H2O; ≥44.87 mg/mL
  3. Apatinib
    B2303 Apatinib
     1 Citation
    Summary: VEGFR2 inhibitor, orally bioavailable, selective
      ≥49.4 mg/mL
  4. LDN-212854
    B3687 LDN-212854
    Summary: BMP receptor inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥20.3 mg/mL
  5. Gefitinib hydrochloride
    A3433 Gefitinib hydrochloride
    Target: EGFR
    Summary: Potent EGFR inhibitor
      insoluble in EtOH; ≥4.28 mg/mL
  6. NT157
    B7808 NT157
     1 Citation
    Summary: IRS-1/2 inhibitor, inhibits IGF-1R and STAT3 signaling pathway
  7. Afatinib (BIBW2992)
    A8247 Afatinib (BIBW2992)
     1 Citation
    Target: EGFR
    Summary: Irreversible EGFR/HER2 inhibitor
      ≥24.3 mg/mL
  8. Nintedanib (BIBF 1120)
    A8252 Nintedanib (BIBF 1120)
     3 Citation
    Target: VEGFR|PDGFR|FGFR
    Summary: VEGFR/PDGFR/FGFR inhibitor
      insoluble in H2O; insoluble in EtOH; ≥5.34 mg/mL
  9. R406
    A8546 R406
     1 Citation
    Target: Syk
    Summary: SYK inhibitor,potent and ATP-competitive
      ≥31.45 mg/mL
  10. R406 (free base)
    A5880 R406 (free base)
    Summary: Syk inhibitor
      ≥23.5 mg/mL

Items 11-20 of 20

Page
per page